DoW Neurofibromatosis Research Academy - Leadership Award
This grant funds established neurofibromatosis researchers to lead a virtual academy, mentor early-career investigators, and conduct collaborative pilot research projects.
Funder: Defense Health Agency Contracting Activity - DHACA
Due Dates: August 31, 2026 (Pre-Application/LOI) | September 14, 2026 (Full Application) | September 21, 2026 (End of Verification Period)
Funding Amounts: Up to $2.4M total costs for a 4-year period; one award expected.
Summary: Supports established neurofibromatosis investigators to lead a virtual, multi-institutional research academy and conduct collaborative pilot projects.
Key Information: Two PIs required (Director and Deputy Director from different institutions); clinical trials are not allowed.
Description
This opportunity funds the leadership of the Neurofibromatosis Research Academy, seeking two established neurofibromatosis (NF) investigators to serve as Academy Director and Deputy Director. The Academy will be a multi-institutional, interactive, virtual platform for mentoring early-career NF researchers (Scholars) and fostering collaborative pilot research projects. The program aims to enhance capacity, mentorship, and research impact in neurofibromatosis and schwannomatosis, supporting the development of future leaders in the field.
The Academy Leadership will:
- Design and manage the Academy structure and activities.
- Mentor and support early-career NF scholars.
- Conduct collaborative pilot research projects with scholars.
- Foster communication, collaboration, and professional development.
- Establish and work with a Patient Advocacy Panel.
- Organize annual and biennial workshops for the Academy community.
Clinical trials are not permitted under this mechanism.
